Rebecca A. Tobin
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MDBiomarkers: A queryable biomarkers database integrating multiple serum and tissue datasets for Duchenne muscular dystrophy.
Journal: Journal of neuromuscular diseases
Published: June 03, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.
Journal: Skeletal muscle
Published: February 11, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroids.
Journal: medRxiv : the preprint server for health sciences
Published: January 08, 2026
Prednisone, not vamorolone, suppresses novel serum bone and cartilage biomarkers associated with growth failure in children with Duchenne muscular dystrophy.
Journal: Scientific reports
Published: December 22, 2025
Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients.
Journal: Scientific reports
Published: July 23, 2025
Test-Retest Reliability of Motor Function and Myometry Outcomes From the Vamorolone Trials in Duchenne Muscular Dystrophy.
Journal: Neurology. Genetics
Published: February 20, 2025
Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical Trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 01, 2024
Modelling lifespan reduction in an exogenous damage model of generic disease.
Journal: Scientific reports
Published: May 11, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026